Cipla Opens Up To Crowd Sourcing Innovation
Executive Summary
Cipla has outlined its intent to incubate disruptive ideas in the healthcare space, along the lines of similar initiatives to accelerate innovation from US/European big pharma. It hopes that this "culture" will expand in India.
You may also be interested in...
Cipla Backs Start-Up As It Builds Digital Health Strategy
Cipla has picked up a minority holding in the Indian digital therapeutics firm Wellthy, and the duo will combine forces to improve patient outcomes in specific chronic therapies.
J&J Opens First JLABS Site In Europe
Johnson & Johnson Innovation has opened its first JLABS incubator in Europe, the 10th worldwide, with close links to its pharma R&D unit Janssen.
Sun Pharma boss and ex-Teva CEO shine light into Israeli life science investor Bio-Light
It's not every day that you hear of Teva Pharmaceutical Industries' ex-CEO, Israel Makov, and Sun Pharma's founder chairman and managing director, Dilip Shanghvi, becoming co-investors in a life science technology investment firm.